352 related articles for article (PubMed ID: 23039208)
1. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
[TBL] [Abstract][Full Text] [Related]
2. Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
Trinh QD; Schmitges J; Bianchi M; Sun M; Shariat SF; Sammon J; Jeldres C; Zorn K; Sukumar S; Perrotte P; Graefen M; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
BJU Int; 2012 Jul; 110(2 Pt 2):E21-7. PubMed ID: 22044638
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
Lughezzani G; Capitanio U; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Perrotte P; Montorsi F; Karakiewicz PI
Cancer; 2009 Dec; 115(24):5680-7. PubMed ID: 19824083
[TBL] [Abstract][Full Text] [Related]
4. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
5. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma.
Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J
Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
[TBL] [Abstract][Full Text] [Related]
7. [Pathological prognostic indicators in renal cell carcinoma].
Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
9. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
10. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
[TBL] [Abstract][Full Text] [Related]
11. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
Capitanio U; Perrotte P; Zini L; Jeldres C; Shariat SF; Isbarn H; Arjane P; Peloquin F; Pharand D; Montorsi F; Karakiewicz PI
BJU Int; 2009 Sep; 104(6):795-9. PubMed ID: 19389018
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
Capitanio U; Jeldres C; Patard JJ; Perrotte P; Zini L; de La Taille A; Ficarra V; Cindolo L; Bensalah K; Artibani W; Tostain J; Valeri A; Zigeuner R; Méjean A; Descotes JL; Lechevallier E; Mulders PF; Lang H; Jacqmin D; Karakiewicz PI
BJU Int; 2009 Jan; 103(1):33-7. PubMed ID: 18990161
[TBL] [Abstract][Full Text] [Related]
13. Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.
Trinh QD; Sukumar S; Schmitges J; Bianchi M; Sun M; Shariat SF; Sammon JD; Jeldres C; Zorn KC; Perrotte P; Graefen M; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
Ann Surg Oncol; 2013 Jun; 20(6):2096-102. PubMed ID: 23263779
[TBL] [Abstract][Full Text] [Related]
14. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
15. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
Karakiewicz PI; Trinh QD; Bhojani N; Bensalah K; Salomon L; de la Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Schips L; Zigeuner R; Mulders PF; Valeri A; Descotes JL; Mejean A; Patard JJ
Eur Urol; 2007 Jun; 51(6):1616-24. PubMed ID: 17207909
[TBL] [Abstract][Full Text] [Related]
17. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
18. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
19. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
[TBL] [Abstract][Full Text] [Related]
20. [Results of radical nephrectomy for renal cell carcinoma. Report 1. Analysis according to the TNM staging system of the general rule for clinical and pathological studies on renal cell carcinoma].
Nishio Y; Nishimura K; Hida S; Okada Y; Takeuchi H; Miyakawa M; Okada K; Yoshida O
Hinyokika Kiyo; 1987 Mar; 33(3):337-43. PubMed ID: 3618401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
